Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-25-102987
Filing Date
2025-10-28
Accepted
2025-10-28 11:07:40
Documents
1
Effectiveness Date
2025-10-28

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2529486d8_s8pos.htm S-8 POS 37612
  Complete submission text file 0001104659-25-102987.txt   38792
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-275131 | Film No.: 251422203
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)